As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies
Fierce Pharma
DECEMBER 9, 2023
BCMA-targeted therapies are transforming care for multiple myeloma patients. But these immunotherapies also come with various potentially dangerous side effects. |
Let's personalize your content